AKAP9(1-1118)-p-BRAF(381-766) fusion [cytosol]

Stable Identifier
R-HSA-6802514
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
15630448 Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

Kerler, R, Fagin, JA, Rabes, HM, Nikiforov, YE, Knauf, JA, Gandhi, M, Ciampi, R, Zhu, Z, Nikiforova, MN

J. Clin. Invest. 2005
Participates
Other forms of this molecule
Modified Residues
Name
Insertion of residues 381 to 766 at 1119 from UniProt:P15056 BRAF
Coordinate
1119
Name
O-phospho-L-serine at 446
Coordinate
446
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Name
O-phospho-L-serine at 729
Coordinate
729
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Name
O-phospho-L-threonine at 599
Coordinate
599
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-threonine residue to O-phospho-L-threonine.
Name
O-phospho-L-serine at 602
Coordinate
602
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Disease
Name Identifier Synonyms
thyroid cancer DOID:1781 Thyroid gland neoplasm, thyroid cancer, thyroid neoplasm, neoplasm of thyroid gland, thyroid neoplasm, Thyroid neoplasm, malignant tumour of thyroid gland, malignant neoplasm of thyroid gland
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cross References
OpenTargets
GeneCards
PRO
Pharos - Targets
GlyGen
Orphanet
HMDB Protein
Cite Us!